Gold in innovative science and technology markets, industrial, medical and dental uses. Training and development news

www.science.gold.org

Hello, you either have JavaScript turned off or an old version of Adobe's Flash Player. Get the latest Flash player.

Gold

Gold nanoparticles help deliver cancer-fighting drugs > Gold News > World Gold Council, gold and science, industrial, technological and medical applications

 

Gold nanoparticles help deliver cancer-fighting drugs

The news feeds on this site are independently provided by Adfero Limited © and do not represent the views or opinions of the World Gold Council.

Wednesday, 23rd July 2008 (2441 views)

New research from the Case Western Reserve University has cut the delivery time of cancer-fighting drugs by using gold nanoparticles.

It currently takes up to two days for the drugs to be delivered to diseased areas in the body.

However, testing on mice has cut the time down to hours instead of days.

The system was created by Clemens Burda, associate professor of chemistry and director of the Centre for Chemical Dynamics and Nanomaterials Research at Case Western Reserve University and graduate student Yu Cheng.

"The system uses gold nanoparticle vectors to deliver photodynamic therapy (PDT) drugs through the bloodstream to cancerous sites," said the university.

According to Mr Burda, gold is non-toxic to the body and so that is why they chose it to deliver the PDT drugs.

Gold nanoparticles also don't interact with proteins in the bloodstream and therefore the drug is kept safe until it reaches cancerous cells.

In 2006, researchers from the Georgia Institute of Technology and the University of California found gold nanorods can help to detect and kill cancer cells.

 

« Back to Gold News stories

 

Gold News Archive:

 
 
News provided by Adfero Ltd

Search

Search our Gold Science & Technology content.

  • Gold Spot Price
  • Bid: $1166.50
  • Ask: $1167.30
  • Last Update: 05:53 GMT
© 2009 World Gold Council - all rights reserved. Produced and managed by CFP Group.